Case report of a poorly differentiated uterine tumour with t(10;17) translocation and neuroectodermal phenotype

Anticancer Res. 2011 Jun;31(6):2367-71.

Abstract

Endometrial stromal sarcoma (ESS) with primitive neuroectodermal differentiation is a very uncommon entity. Such a case presenting as stage IIIc (International Federation of Gynaecology and Obstetrics (FIGO) 2010) disease in a 51-year-old female is described. Microscopy suggested a small blue round cell tumour. Cytogenetic and multicolour fluorescent in situ hybridisation (M-FISH) analysis revealed a complex karyotype with the presence of unbalanced t(10;17)(q22;p13) translocation, indicating ESS. Peripheral Ewing´s sarcoma was excluded based on FISH and RT-PCR fusion transcripts analysis. After surgical staging, the patient received bleomycin-etoposide-cisplatin combination chemotherapy. A detailed analysis of the histopathology and genetic findings forms the basis of this report.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Bleomycin / administration & dosage
  • Cell Differentiation / physiology
  • Chromosomes, Human, Pair 10*
  • Chromosomes, Human, Pair 17*
  • Cisplatin / administration & dosage
  • Etoposide / administration & dosage
  • Female
  • Humans
  • Neuroectodermal Tumors / drug therapy
  • Neuroectodermal Tumors / genetics
  • Neuroectodermal Tumors / pathology*
  • Phenotype
  • Sarcoma, Endometrial Stromal / drug therapy
  • Sarcoma, Endometrial Stromal / genetics*
  • Sarcoma, Endometrial Stromal / pathology
  • Translocation, Genetic*
  • Uterine Neoplasms / drug therapy
  • Uterine Neoplasms / genetics*
  • Uterine Neoplasms / pathology

Substances

  • Bleomycin
  • Etoposide
  • Cisplatin